The aim is to evaluate the FDA's efforts in reducing unnecessary animal testing and propose viable alternatives.
Review of FDA's initiatives
Discussion of human-relevant testing alternatives
Analysis of regulatory impacts
Highlighting significant achievements by the FDA in minimizing animal testing
Identifying potential methodologies that could replace animal testing
Suggesting future directions for regulatory change
Abstract
This Perspective reviews the US Food and Drug Administration’s achievements toward eliminating unnecessary animal-based testing and outlines more human-relevant changes for the future.